Director/PDMR Shareholding

By

Regulatory News | 18 Jan, 2019

Updated : 10:18

RNS Number : 5152N
Chemring Group PLC
18 January 2019
 

18 January 2019

 

Chemring Group PLC

 

PDMR share dealing

 

Chemring Group PLC ("Chemring" or "the Company") announces that it has been notified that Carl-Peter Forster, a director of the Company, purchased 10,000 1p ordinary shares in the capital of the Company at an average price of 164.6p per share on 17 January 2019.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Carl-Peter Forster

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

 

 

b)

 

Nature of the transaction

 

 

Purchase of 1p ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

164.6p

 

10,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

10,000 1p ordinary shares

 

 

164.6p per share

 

e)

 

Date of the transaction

 

 

17 January 2019

f)

 

Place of the transaction

 

 

UK

 

 

For further information:

 

Chemring Group PLC

 

Sarah Ellard

Group Legal Director

+44 (0)1794 833 901

   

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFLILEITLIA

Last news